Robert Tjian
Article Abstract:
Biochemist Robert Tjian built a mega-biotech conglomerate Turalik in January 1992, which wanted to discover drugs based on understanding of how genes are controlled inside the cell through transcription factors and to make drugs in the form of pills. Thousand Oaks, California-based Amgen acquired Turalik in March 2003 as it had the right scientists, an attribute that can take a company much further than the right science.
Publication Name: Nature Biotechnology
Subject: Business
ISSN: 1087-0156
Year: 2006
User Contributions:
Comment about this article or add new information about this topic:
Tracking down tissues
Article Abstract:
The inspection of several tissue banks and procurement facilities by the Human Tissue Task Force (HTTF), an internal U.S. Food and Drug Administration (FDA) body, has revealed that the tracking systems and regular audits should be improved. The companies are trying to find their own ways of collecting materials and determining its quality as the demand for human tissues for drug research and development is growing.
Publication Name: Nature Biotechnology
Subject: Business
ISSN: 1087-0156
Year: 2007
User Contributions:
Comment about this article or add new information about this topic:
Cellulosic ethanol booms despite unproven business models
Article Abstract:
A new trend of using lignocellulosic feedstocks such as corn stover, grasses and wood chips as alternative biofuels is gaining significance. The use of lignocellulosic ethanol is increasing commercially as many biochemical industries are building production facilities and setting up plants.
Publication Name: Nature Biotechnology
Subject: Business
ISSN: 1087-0156
Year: 2008
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: Another brick in the wall. Talking and walking. The schmoozing ruse
- Abstracts: A rose by any other name. Printing by numbers. Nightmare on e-street
- Abstracts: The expert patient. The gift of life. Alcoholism-nature or nurture?
- Abstracts: Imperfect information: The persistence of price dispersion on the web. The negative effect of policy restrictions on consumers' post-purchase reactions to price-matching guarantees
- Abstracts: Antiinfective biotechs face partnering gap. A taste of the future